| Literature DB >> 27478196 |
Min-Hoe Chew1, Yu-Ting Yeh2, Evan Lim3, Francis Seow-Choen4.
Abstract
The advent of total mesorectal excision (TME) together with minimally invasive techniques such as laparoscopic colorectal surgery and robotic surgery has improved surgical results. However, the incidence of bladder and sexual dysfunction remains high. This may be particularly distressing for the patient and troublesome to manage for the surgeon when it does occur. The increased use of neoadjuvant and adjuvant radiotherapy is also associated with poorer functional outcomes. In this review, we evaluate current understanding of the anatomy of pelvic nerves which are divided into the areas of the inferior mesenteric artery pedicle, the lateral pelvic wall and dissection around the urogenital organs. Surgical techniques in these areas are discussed. We also discuss the results in functional outcomes of the various techniques including open, laparoscopic and robotic over the last 30 years.Entities:
Keywords: pelvic autonomic nerve preservation; sexual dysfunction; total mesorectal excision; urinary dysfunction
Year: 2016 PMID: 27478196 PMCID: PMC4976685 DOI: 10.1093/gastro/gow023
Source DB: PubMed Journal: Gastroenterol Rep (Oxf)
Figure 1General overview of anatomy of the autonomic nerve distribution. The superior hypogastric plexus around the inferior mesenteric artery descends to the sacral promnotry and bifurcates into hypogastric nerves. These usually run 1–2 cm medial to the ureters and cross the common iliac arteries and S1 in the sacrum.
Figure 2Inferior hypogastric nerve with branches to the rectum on a robotic view with medial-to-lateral dissection approach.
Figure 3Anatomy of the pelvic autonomic nerves with relation to rectum. The inferior hypogastric plexus comprises nerves from the hypogastric and pelvic splanchnic nerves at lateral pelvic wall.
Figure 4The relationship of the rectum and pelvic autonomic nerves during open surgery when standing on the patient’s left. The ligation of the inferior mesenteric artery should be performed 1.5–2 cm from its origin from the aorta to avoid damaging the superior hypogastric plexus. At the pelvis, for posterior and lateral tumours, dissection should be directed below the Denonvillliers fascia to avoid damaging the neurovascular bundles that run along the tip of the seminal vesicle (2 and 10 o’clock directions).
Incidence of urinary dysfunction when comparing open, laparoscopic and robotic total mesorectal excision (TME)
| Literature | Year of publication | Study design | Procedure type | Subjects evaluated | Duration of follow-up (months) | Complications |
|---|---|---|---|---|---|---|
| Hojo | 1990 | Case series - Retrospective | TME and ANP | 134 | 12 | Multi-level sacrifice of HP and PP contributes to more severe urinary dysfunction and increasing bladder hypertonia |
| Havenga | 1996 | Case series - Retrospective | TME | 136 | No significant change in both male and female urinary function | |
| Sugihara | 1996 | Case series - Prospective | TME and ANP | 199 | 12 |
Urinary dysfunction: 0% in intact HP and PP 3.9% in sacrifice HP and intact bilateral PP 6.5% in sacrifice HP and unilateral PP 30.8% in complete resection of pelvic autonomic nerves |
| Saito | 1998 | Case series | TME and ANP | 167 | No requirement for long-term indwelling catheter | |
| Ishikura | 1999 | Case series - Prospective | TME and ANP with PLND | 49 | Median 41 | Urinary dysfunction in both sexes: 18.4% |
| Maas | 2000 | Case series - Prospective | TME and ANP with radical rectal resection | 47 | Median 42 | Urinary frequency in both sexes: 22%; |
| Minor incontinence in both sexes: 19% | ||||||
| Nesbakken | 2000 | Case series - Prospective | TME | 49 | 3 | No significant change in urinary symptom score (both sexes) except for increase in female incontinence score |
| Maurer | 2001 | Case control | TME | 60 | Minimum 3 | No significant change in urinary symptom among both groups |
| Pocard | 2002 | Case series - Prospective | TME | 20 | Up to 60 | Both sexes requiring indwelling catheter: 0%. |
| No significant change in urinary symptom score (both sexes). | ||||||
| Kim | 2002 | Case series - Prospective | TME | 68 | Median 8.7 | Males requiring long-term indwelling catheter: 0%. |
| No significant change of male IPSS score. | ||||||
| Junginger | 2003 | Case series - Prospective | TME with pelvic plexus visualisation | 150 | Median 24 | Overall urinary dysfunction (both sexes): 12%. |
| Complete or partially visualised ANP 4.5% | ||||||
| Required short-term indwelling catheter (both sexes) : 10.7%. | ||||||
| Kneist | 2004 | Cohort study | TME or partial mesorectal excision | 229 | Overall urinary dysfunction (both sexes): 4.1% with complete ANP | |
| Both sexes long-term indwelling catheter 8.8%. | ||||||
| Shirouzu | 2004 | Case control | TME with | 292 | Median 218 | Overall urinary dysfunction (both sexes): < 20% with complete ANP |
| Sterk | 2005 | Case series - Prospective | TME | 52 | 3 | Urinary dysfunction (both sexes): 24.4% at 14 days and 8.1% at 3 months |
| Wang | 2005 | Case control | Open TME with | 96 | Female urinary dysfunction: 6.25% with ANP | |
| Residual urine > 50 ml: 10.41% with ANP | ||||||
| Significantly longer duration to recover from urinary symptoms in patients without ANP. | ||||||
| Laing | 2006 | Case control | Open TME with | 236 | Overall male urinary dysfunction: 12.71% with ANP | |
| Kyo | 2006 | Case control | Open TME and ANP with | 37 | Minimum 7 | Male urinary dysfunction: 33% with PLND |
| Dong | 2007 | Case series - Retrospective | Open TME with ANP | 124 | Failed urinary catheter removal on post-op day 3: 9.7% | |
| Kneist | 2007 | Cohort study | Open TME, operative bladder neurophysiology monitor with | 62 | Median 20 | Urinary dysfunction (both sexes): 2.1% with complete ANP |
| Both sexes required long-term indwelling catheter: 2.1% with ANP | ||||||
| Significantly worse in urinary symptom score without ANP. | ||||||
| Akasu | 2009 | Case series - Prospective | LAR/APR with selected ANP and PLND | 69 | 0.5 | Residual urine > 50 ml at day 14 (SD) |
| Bilateral pelvic-plexus preservation without PLND: 4% | ||||||
| Bilateral pelvic-plexus preservation with PLND: 27% | ||||||
| Unilateral pelvic-plexus preservation with PLND: 76% | ||||||
| No pelvic-plexus preservation with PLND: 100% | ||||||
| Zhao | 2011 | Case control | Open TME and ANP | 84 | Up to 24 | Male urinary dysfunction: 24.4% in TME and ANP |
| Cakabay | 2012 | Case series - Prospective | TME | 20 | 12 | Male urinary dysfunction: 25% |
| Male requiring long-term indwelling catheter: 5% | ||||||
| Quah | 2002 | Randomized controlled trial | Laparoscopic assisted | 80 | Median 36 | Urinary dysfunction (both sexes): 0%. |
| Males required long-term indwelling catheter: 2.5% in laparoscopic | ||||||
| Females required long-term indwelling catheter: 2.5% in laparoscopic | ||||||
| Jayne | 2005 | Randomized controlled trial | Laparoscopic colonic | 246 | Up to 76 | Urinary dysfunction (both sexes): 21% in laparoscopic colonic, 35% in open/laparoscopic rectal. |
| No significant change in urinary symptom score after 6 months. | ||||||
| Liang | 2007 | Case series - Prospective | Laparoscopic TME | 74 | Minimum 3 | Urinary dysfunction (both sexes): 17.6% |
| Kim | 2012 | Cohort study | Laparoscopic | 38 | 12 | Urinary dysfunction (both sexes): 3.3% in robotic |
| McGloen | 2012 | Cohort study | laparoscopic | 143 | Minimum 6 | No significant change in urinary symptom score (both sexes) |
| D’Annibale | 2013 | Cohort study | Laparoscopic | 60 | 12 | Male urinary dysfunction: 0% |
| Runkel | 2013 | Case series - Prospective | Laparoscopic nerve orientated mesorectal excision | 274 | 12 | Male requiring long-term indwelling catheter: 0.5% |
| Luca | 2013 | Case series - Prospective | Totally robotic TME | 74 | 17.03 | Male urinary dysfunction: 0% |
| Female urinary dysfunction: 0% | ||||||
| Hur | 2013 | Non-randomized control trial | Laparoscopic | 97 | 12 | Urinary dysfunction (both sexes): 5.4% in laparoscopic |
| Required long-term indwelling catheter (both sexes): 0%. | ||||||
| No significant changes in IPSS score between both groups. | ||||||
| Zeng | 2013 | Cohort study | Laparoscopic | 81 | 6 | Overall male urinary dysfunction: 16.28% in laparoscopic |
| Park | 2014 | Case control | Laparoscopy | 64 | 12 | No difference in IPSS scores |
ANP: autonomic nerve preservation; PLND: pelvic lymph node dissection; IPSS: International Prostate Symptom Score; SD: statistical significant difference; HP: Hypogastric plexus; PP: Pelvic Plexus
Incidence of sexual dysfunction when comparing open, laparoscopic and robotic total mesorectal excision (TME)
| Literature | Year of publication | Study design | Procedure type | Subjects evaluated | Duration of follow-up (months) | Complications |
|---|---|---|---|---|---|---|
| Hojo | 1990 | Case series - Retrospective | TME and ANP | 39 | 12 | Male erectile dysfunction: 69% |
| Male ejaculatory dysfunction: 85% | ||||||
| Havenga | 1996 | Case series - Retrospective | TME | 136 | Male ejaculatory dysfunction: 13% | |
| < 60 year-old sexual dysfunction (both sexes): 14% | ||||||
| > 60 year-old sexual dysfunction (both sexes): 33% | ||||||
| Sugihara | 1996 | Case series - Prospective | TME and ANP | 57 | Median 53 | Male sexual dysfunction with and without ANP: 66.7% |
| Male sexual dysfunction with complete ANP: 29.6% | ||||||
| Male erectile dysfunction with complete ANP: 3.8% | ||||||
| Male erectile dysfunction with incomplete ANP: 20% | ||||||
| Male ejaculatory dysfunction with complete ANP: 18.5% | ||||||
| Male ejaculatory dysfunction with incomplete ANP: 100% | ||||||
| Enker | 1997 | Case control | TME and ANP in APR | 136 | up to 60 | Male sexual dysfunction in LAR: 14% |
| Male sexual dysfunction in APR: 43% | ||||||
| Male ejaculatory dysfunction in LAR: 12% | ||||||
| Male ejaculatory dysfunction in APR: 15% | ||||||
| Female sexual dysfunction: 14% | ||||||
| Female orgasmic dysfunction: 9% | ||||||
| Saito | 1998 | Case series | TME and ANP | 167 | Unsuccessful in preserving sexual function | |
| Ishikura | 1999 | Case series - Prospective | TME and ANP with PLND | 15 | Median 41 | Male sexual dysfunction: 21.5% |
| Maas | 2000 | Case series - Prospective | TME and ANP with radical rectal resection | 47 | Median 42 | Male erectile dysfunction 8.3% with preserved SHP and 100% without complete preservation of ANP. |
| Male ejaculatory dysfunction 12.5% with preserved SHP and 100% with sacrifice of SHP. | ||||||
| Female dyspareunia: 66.7% | ||||||
| Nesbakken | 2000 | Case series - Prospective | TME | 49 | 6 | Male erectile dysfunction: 16.7% |
| Male ejaculatory dysfunction: 7.6% | ||||||
| Female orgasmic dysfunction: 0% | ||||||
| Maurer | 2001 | Case control | TME | 60 | Minimum 3 | Male sexual dysfunction increased from 33% preop to 93% postop in conventional group |
| Male erectile dysfunction increased from 25% preop to 94% postop in conventional group | ||||||
| Male ejaculatory dysfunction increased from 12% preop to 91% postop in conventional group | ||||||
| Insufficient data for female sexual dysfunction analysis | ||||||
| Kim | 2002 | Case series - Prospective | TME | 68 | Median 8.7 | Male erectile dysfunction: 19.1% |
| Male ejaculatory dysfunction: 13.2% | ||||||
| Significant worsening of IIEF Score in all domains | ||||||
| Pocard | 2002 | Case series - Prospective | TME | 20 | Up to 36 | Male erectile dysfunction: 0% |
| Male ejaculatory dysfunction: 11.0% | ||||||
| Female orgasmic dysfunction: 0% | ||||||
| Female dyspareunia: 0% | ||||||
| Wang | 2003 | Case control | Open TME with | 104 | Male erectile dysfunction: 32.7% with ANP | |
| Male ejaculatory dysfunction: 44.2% with ANP | ||||||
| Shirouzu | 2004 | Case control | TME with ANP | 129 | Median 218 | Male erectile dysfunction: 21% with ANP |
| Male ejaculatory dysfunction: 35% with ANP | ||||||
| Sterk | 2005 | Case series - prospective | TME | 29 | 3 | Male erectile dysfunction: 55.1% |
| Male ejaculatory dysfunction: 3.6% | ||||||
| Wang | 2005 | Case series - Retrospective | Open TME | 105 | Male sexual dysfunction: 35.2% | |
| Wang | 2005 | Case control | Open TME with | 105 | Up to 84 | Male erectile dysfunction: 33.3% with ANP |
| Male ejaculatory dysfunction: 43.8% with ANP | ||||||
| Wang | 2005 | Case control | Open TME with | 96 | Female dyspareunia: 4.15% with ANP | |
| Female orgasmic dysfunction: 10.5% with ANP | ||||||
| Female sexual arousal dysfunction: 12.5% with ANP | ||||||
| Laing | 2006 | Case control | Open TME with | 236 | Overall Male erectile dysfunction: 49.15% with ANP | |
| Kyo | 2006 | Case control | TME and ANP with | 30 | Minimum 7 | Male erectile dysfunction: 50% with PLND |
| Male ejaculatory dysfunction: 90% with PLND | ||||||
| Dong | 2007 | Case series - Retrospective | Open TME with ANP | 124 | Male erectile dysfunction: 37.7% | |
| Male ejaculatory dysfunction: 42.9% | ||||||
| Akasu | 2009 | Case series - Prospective | Open LAR/APR with selected ANP and PLND | 66 | 12 | Male erectile dysfunction (SD) |
| Bilateral pelvic-plexus preservation without PLND: 5% | ||||||
| Bilateral pelvic-plexus preservation with PLND: 44% | ||||||
| Unilateral pelvic-plexus preservation with PLND: 55% | ||||||
| No pelvic-plexus preservation with PLND: 100% | ||||||
| Zhao | 2011 | Case control | Open TME and ANP | 84 | Up to 24 | Male erectile dysfunction: 29.3% in TME and ANP |
| Male ejaculatory dysfunction: 26.8% in TME and ANP | ||||||
| Cakabay | 2012 | Case series - Prospective | TME | 20 | Male erectile dysfunction: 5% | |
| Male ejaculatory dysfunction: 10% | ||||||
| Quah | 2002 | Randomized controlled trial | Laparoscopic assisted | 80 | Median 36 | Sexual dysfunction (both sexes) 23.9% in laparoscopic |
| Male erectile dysfunction: 40% in laparoscopic | ||||||
| Male ejaculatory dysfunction: 40% in laparoscopic | ||||||
| Jayne | 2005 | Randomized controlled trial | Laparoscopic rectal | 246 | Up to 76 | Male sexual dysfunction: 41% in laparoscopic rectal, 23% in open rectal and 4% in laparoscopic colonic. |
| Male erectile and ejaculatory dysfunction more common in laparoscopic and open rectal surgery but none in laparoscopic colonic. | ||||||
| Female sexual dysfunction: 28% in laparoscopic rectal, 18% open rectal 18%, and 8% in laparoscopic colonic. | ||||||
| Liang | 2007 | Case series - Prospective | Laparoscopic TME | 60 | 6 | Male erectile dysfunction: 37.5% |
| Male ejaculatory dysfunction: 43.7% | ||||||
| Female orgasmic dysfunction: 32.1% | ||||||
| Female dyspareunia: 39.2% | ||||||
| Liu | 2009 | Randomized control trial | Laparoscopic | 119 | 12 | Male sexual dysfunction: 11.6% in laparoscopic |
| McGloen | 2012 | Cohort study | Laparoscopic | 143 | Minimal 6 | Worse IIEF score in male open group, especially erectile function (SD). |
| Worse FSFI score in female open group (SD). | ||||||
| Kim | 2012 | Cohort study | Laparoscopic | 38 | 12 | Male erectile dysfunction: 13.3% in robotic |
| D’Annibale | 2013 | Cohort study | Laparoscopic | 60 | 12 | Male erectile dysfunction: 5.6% in robotic |
| Luca | 2013 | Case series - Prospective | Totally Robotic TME | 74 | 17.03 | No change in IIEF or FSFI score |
| Runkel | 2013 | Case series - Prospective | Laparoscopic nerve orientated mesorectal excision | 42 | 12 | Male erectile dysfunction: 18.2% |
| Hur | 2013 | Non-randomized control trial | Laparoscopic | 50 | 12 | Male sexual dysfunction: 22.7% in open |
| No significant change of IIEF score by 12 months in both groups. | ||||||
| Zeng | 2013 | Cohort study | Laparoscopic | 81 | 6 | Male erectile dysfunction: 27.91% in laparoscopic |
| Male ejaculatory dysfunction: 25.58% in laparoscopic | ||||||
| Park | 2014 | Case control | Laparoscopic | 64 | 12 | IIEF Scores for robotic group higher at 6 months compared to laparoscopic group |
ANP: autonomic nerve preservation; PLND: pelvic lymph node dissection; SHP: superior hypogastric plexus; APR: abdominoperineal resection; LAR: low anterior resection; IIEF: International index of Erectile Function; FSFI: Female Sexual Function Index; SD: statistical significant difference